These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16698802)

  • 1. Escaping from the TGFbeta anti-proliferative control.
    Seoane J
    Carcinogenesis; 2006 Nov; 27(11):2148-56. PubMed ID: 16698802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TGFbeta-mediated processes in cancer.
    Romano MF
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-metastasis function of TGFbeta mediated by the Smad pathway.
    Kang Y
    J Cell Biochem; 2006 Aug; 98(6):1380-90. PubMed ID: 16598746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of TGFbeta in metastasis.
    Padua D; Massagué J
    Cell Res; 2009 Jan; 19(1):89-102. PubMed ID: 19050696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TGFbeta signaling in skin carcinogenesis.
    Wang XJ
    Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
    Muraoka-Cook RS; Dumont N; Arteaga CL
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):937s-43s. PubMed ID: 15701890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TGFbeta signaling in cancer therapy.
    Arteaga CL
    Curr Opin Genet Dev; 2006 Feb; 16(1):30-7. PubMed ID: 16377175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TGFβ signaling and its implications in anticancer treatments.
    Calone I; Souchelnytskyi S
    Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
    He W; Dorn DC; Erdjument-Bromage H; Tempst P; Moore MA; Massagué J
    Cell; 2006 Jun; 125(5):929-41. PubMed ID: 16751102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of TGFbeta signal transduction.
    Moustakas A; Heldin CH
    Development; 2009 Nov; 136(22):3699-714. PubMed ID: 19855013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
    Wang Y; He QY; Chen H; Chiu JF
    Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFbeta signalling in control of T-cell-mediated self-reactivity.
    Rubtsov YP; Rudensky AY
    Nat Rev Immunol; 2007 Jun; 7(6):443-53. PubMed ID: 17525753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
    Bierie B; Moses HL
    Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFbeta-mediated immunoregulation.
    Peng Y; Gorelik L; Laouar Y; Li MO; Flavell RA
    Ernst Schering Res Found Workshop; 2006; (56):155-60. PubMed ID: 16329651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.
    Gomez-Duran A; Carvajal-Gonzalez JM; Mulero-Navarro S; Santiago-Josefat B; Puga A; Fernandez-Salguero PM
    Biochem Pharmacol; 2009 Feb; 77(4):700-12. PubMed ID: 18812170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.